Dermatopharmacokinetic Trial of LEO 90100 Foam

NCT03476746 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LEO 90100 foam
DRUG: Dovobet® ointment

Sponsor

LEO Pharma